In this proposal, we focus no determining the regulation and biochemical properties of mammalian MAP/ERK kinase kinase 1 (MEKK1). MEKK1 was discovered as a consequence of its similarity to a yeast protein kinase in the mating pheromone response pathway. In transfected fibroblasts MEKK1 activates the c-Jun N-terminal kinases/stress-activated protein kinases (JNK/SAPKs), and to a lesser extent the ERK1/2 and p38 MAP kinases. The ability to control the JNK/SAPK pathway and its biological actions in cells indicate that MEKK1 is primarily linked to responses to stresses, including inflammation and environmental insult. We isolated cDNAs containing the complete coding sequence of MEKK1, a large enzyme with the catalytic domain at the C-terminus and a 1200-residue, noncatalytic N- terminus. We have found that the N-terminal residues of MEKK1 form complexes with other signaling proteins. These interactions may lead to its upstream wiring and its downstream specificity. The behavior of MEKK1 does not fit the paradigm for phosphorylation-activated protein kinases. To understand the regulation and function of MEKK1, the research plan focuses on defining the independent domains in MEKK1, identifying additional proteins that bind to and defining binding sites for the known binding proteins, identifying regulators using molecular biological and biochemical methods and defining their mechanisms of action, and determining enzymatic and pathway specificity through mutagenesis and biochemical analysis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM056498-01
Application #
2396086
Study Section
Biochemistry Study Section (BIO)
Project Start
1997-08-01
Project End
2001-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Raman, M; Chen, W; Cobb, M H (2007) Differential regulation and properties of MAPKs. Oncogene 26:3100-12
Gallagher, Ewen D; Gutowski, Stephen; Sternweis, Paul C et al. (2004) RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity. J Biol Chem 279:1872-7
Chen, Wei; White, Michael A; Cobb, Melanie H (2002) Stimulus-specific requirements for MAP3 kinases in activating the JNK pathway. J Biol Chem 277:49105-10
Gallagher, Ewen D; Xu, Shuichan; Moomaw, Carolyn et al. (2002) Binding of JNK/SAPK to MEKK1 is regulated by phosphorylation. J Biol Chem 277:45785-92
Lu, Zhimin; Xu, Shuichan; Joazeiro, Claudio et al. (2002) The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Mol Cell 9:945-56
Lee, H Y; Suh, Y A; Robinson, M J et al. (2000) Stress pathway activation induces phosphorylation of retinoid X receptor. J Biol Chem 275:32193-9
Karandikar, M; Xu, S; Cobb, M H (2000) MEKK1 binds raf-1 and the ERK2 cascade components. J Biol Chem 275:40120-7
Christerson, L B; Vanderbilt, C A; Cobb, M H (1999) MEKK1 interacts with alpha-actinin and localizes to stress fibers and focal adhesions. Cell Motil Cytoskeleton 43:186-98
Xu, S; Cobb, M H (1997) MEKK1 binds directly to the c-Jun N-terminal kinases/stress-activated protein kinases. J Biol Chem 272:32056-60